Low Utilization of Predictive Lab Test for Cardiac Events in the US Despite Modest Increase

Researchers from the University of California San Diego School of Medicine have discovered that the testing for lipoprotein(a) as a genetic risk factor for heart disease continues to be uncommon in the United States. Despite some modest increases over the past decade, the utilization of this predictive lab test remains low. The findings indicate that there is still a significant gap in incorporating this critical test into routine cardiovascular screenings. This highlights the need for greater awareness and promotion of testing for lipoprotein(a) among healthcare providers and the general population.